Johns Hopkins

Can An Anti-Parasitic Medication, Treat Brain Cancer?

We are funding a clinical trial at Johns Hopkins to test whether mebendazole, a drug already approved by the FDA to fight infections, might be an effective anti-brain cancer medication.  This drug has a strong safety profile and is available as a generic, which could be widely available in the near term and at a low cost to patients.  

7/28/2015 UPDATE:  The Hopkins team has successfully completed the Phase I GBM clinical trial for the use of the anti-worming medication Mebendazole.  The results were encouraging and we are now working with them to raise the funds necessary to move the drug into Phase II trials.  We are also working with them to possibly launch a pediatric clinical trial. 

Share |

Join us in our fight for a cure!